Q2 2026 M&A Update
As part of our quarterly pharmaceutical industry review, we are pleased to share an update on merger and acquisition activity to help our clients understand the market dynamics impacting pharmaceutical…
Q1 2026 M&A Update
As part of our quarterly pharmaceutical industry review, we are pleased to share an update on merger and acquisition activity to help our clients understand the market dynamics impacting pharmaceutical…